v3.23.2
Equity (Tables)
9 Months Ended 12 Months Ended
Mar. 31, 2023
Jun. 30, 2022
Stockholders' Equity Note [Abstract]    
Schedule of fair value of each equity-based award is estimated period

Stock price volatility

 

175%

Expected term

 

5 years

Discount rate

 

3.38%

Expected dividends

 

0%

Stock price volatility

 

190%

Expected term

 

1 year

Risk-free interest rate

 

3.21%

Expected dividends

 

0%

Stock price volatility

190%

Expected term

1 year

Risk-free interest rate

3.21%

Expected dividends

0%

Schedule of warrant status

 

 

 

 

Warrants

 

Weighted Average Exercise Price

 

Outstanding, June 30, 2022

600,000

 

 $0.01

 

Granted

1,400,000

 

0.01

 

Granted

2,100,000

 

0.10

 

Forfeited

-

 

-

 

Outstanding, March 31, 2023

 4,100,000

 

$0.09

 

 

 

 

 

 

Exercisable, end of period

$3,100,000

 

-

 

 

Warrants

Weighted Average Exercise Price

Outstanding, beginning of year

-

$  -

 Granted

600,000

0.50

 Forfeited

-

-

Outstanding, end of year

600,000

$ 0.50

 

Exercisable, end of year

600,000

Schedule of warrants outstanding

 

 

Exercise

 

Number

 

Number

 

Weighted Average

 

Intrinsic

Warrants

 

Price

 

Exercisable

 

Outstanding

 

Remaining Life

 

Value

600,000

 

$ 0.01

 

600,000

 

600,000

 

 4.5 years

 

$  -

1,000,000

 

$ 0.01

 

-

 

1,000,000

 

 4.7 years

 

$ 150,000

 400,000

 

$ 0.01

 

400,000

 

400,000

 

 4.5 years

 

$ 243,250

2,100,000

 

$ 0.10

 

2,100,000

 

2,100,000

 

 4.9 years

 

$  99,184

2,100,000

 

$ 0.10

 

-

 

-

 

 5 years

 

$  -

 

 

Warrants

 

 

Exercise price

 

Number Exercisable

 

Number Outstanding

Weighted Average Remaining Life

 

 

Intrinsic Value

600,000

$ 0.50

600,000

600,000

5 years

Amount is negligible